je.st
news
GSK, Prosensa muscular dystrophy drug misses study goal
2013-09-20 17:19:30| Biotech - Topix.net
An experimental drug for Duchenne muscular dystrophy from GlaxoSmithKline and Prosensa failed to meet its goal in a late-stage clinical trial, sending shares in Prosensa tumbling 75 percent in pre-market trade.
Tags: study
goal
drug
muscular
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||